Nanoparticle drug delivery helps reduce tumour metastasis http://bit.ly/cVK8FK $ABII $CELG

$CELG getting some respect this morning. Acquisition of $ABII and upgrade to buy from neutral at Summer Street should help.

Celgene plans to expand cancer pipeline by acquiring Abraxis for $2.9B in cash and stock $ABII $CELG http://yhoo.it/a7YXBw

Celgene plans to expands cancer pipeline by acquiring Abraxis for $2.9B in cash and stock $ABII $CELG http://yhoo.it/a7YXBw

It's access to nanotechnology that I like most about the $CELG $ABII deal: http://bit.ly/8HmhaD

My take on the $CELG $ABII deal: http://bit.ly/dBRjEi

Good morning. Buying $CELG here at 49.95, nice price drop due to acquisition of $ABII, I think this is fully priced in and will boost.

Biotech buyout bonanza! M&A in health care is really picking up. Celgene buying Abraxis for $2.9B. $ABII up 21% pre-market. $CELG down 2%.

CELG to Purchase ABII for Approx. $71.93/Share http://bit.ly/9oWoKi $ABII

“@adamfeuerstein: @MaverickNY The $CELG-$ABII It seems $CELG likes reformulated old drugs.

$SNY are buying TargeGen, which has a JAK2 inhibitor in development for myeloproliferative disorders. Bit overshadowed by $CELG-$ABII news

Wake up to find inbox is telling me $CELG buying $ABII for nearly $3B?! *pinches self*

$CELG acquire $ABII for $58 in cash and 0.2617 shares. Also each $ABII share will receive one tradeable CVR for future payouts